Viewing Study NCT05902494

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:45 AM
Ignite Modification Date: 2026-02-24 @ 10:55 AM
Study NCT ID: NCT05902494
Status: COMPLETED
Last Update Posted: 2025-07-20
First Post: 2023-06-05
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: HER2 and LA/mUC: A Multi-country Chart Review Cohort Study
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Urothelial Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Urothelial Cancer View
None Bladder Cancer View
None HER2 Mutations View
None HER2 Overexpression View
None HER2 Amplification View
None Seattle Genetics View